Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Donein25on Nov 30, 2023 8:50am
232 Views
Post# 35760533

RE:RE:RE:RE:1St quarter BTD

RE:RE:RE:RE:1St quarter BTDAnabelsi, Most of us are invested in TLT because we believe that 450 day CR will soon drive share price, catapult TLT to the forefront of SOC and eventually lead to a buyout. The delays that you are fixated on are agreeably frustrating, especially for those of us, like myself, who have been here for 10 years. But deal with it. It comes with the territory when investing in a small cap biotech. If you and folks like Budfoxx can't see that, then maybe you should find another investment that suites your tolerance level better. But I hope you will stay, because the CR does dictate the futue of your investment. Be confident in that.
<< Previous
Bullboard Posts
Next >>